TAP Prevacid Consumer Campaign Will Include Nexium Comparison
Executive Summary
TAP's Prevacid consumer promotions will include study data comparing the product to AstraZeneca's Nexium (esomeprazole) that will be published by the end of March
You may also be interested in...
Abbott Will Outlicense Ketolide Antibiotic, Focus On Quinolone And D2E7
Abbott is seeking to outlicense its ketolide antibiotic ABT-773 in lieu of expanding Phase III development to address class issues
Abbott Will Outlicense Ketolide Antibiotic, Focus On Quinolone And D2E7
Abbott is seeking to outlicense its ketolide antibiotic ABT-773 in lieu of expanding Phase III development to address class issues
Protonix, Nexium Growing Share, Wyeth Says; No Prilosec Generic In '01
Wyeth-Ayerst's Protonix and AstraZeneca's Nexium are the only proton pump inhibitors growing market share, Wyeth Pharmaceuticals President Bernard Poussot said during an Oct. 23 conference call.